First-line treatment with trastuzumab deruxtecan (T-DXd) significantly improved progression-free survival compared with ...

Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients ...

An exploratory 8-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to provide a ...

Results from the phase 3 PAPILLON study show that first-line amivantamab plus carboplatin-pemetrexed ...

An international research team that included Martín Hugo, a Serra Húnter lecturer in the Department of Biochemistry and ...

A new modeling study published in The Lancet suggests that U.S. Medicare's new "Most-Favored-Nation" pricing policy, which ...

Over the past few decades, antibody-based therapies have revolutionized modern medicine and are now widely used to treat ...

New results from the global phase 1/2 ARROS-1 trial showed clinically meaningful activity with zidesamtinib in patients with ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that small populations of pancreatic cancer cells can ...

A new perspective from LSU's Pennington Biomedical Research Center proposes a new way of understanding how dietary protein ...

Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed ...

When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have ...